Regeneron's Partner Play: What Biohaven's Latest Deal Says About Pipeline Priorities The recent clinical supply agreement between Biohaven and Regeneron has sparked debate about the company's pipeline priorities.
On its surface, the deal appears to be a savvy move by Biohaven to tap into Regeneron's commercial expertise. However, upon closer inspection, it reveals a more nuanced picture of Biohaven's strategic approach.
A Tale of Two Biotechs The contrast between Biohaven and Regeneron is striking.